<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-07-19" modified="2018-01-31" version="166">
<accession>Q9UBE8</accession>
<accession>B2RCX1</accession>
<accession>Q2PNI9</accession>
<accession>Q6P2A3</accession>
<name>NLK_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein kinase NLK</fullName>
<ecNumber>2.7.11.24</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Nemo-like kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Protein LAK1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NLK</name>
<name type="synonym" evidence="23">LAK1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1" evidence="24">
<citation type="journal article" date="2000" name="Gene" volume="251" first="63" last="71">
<title>Characterization of the Fugu rubripes NLK and FN5 genes flanking the NF1 (Neurofibromatosis type 1) gene in the 5' direction and mapping of the human counterparts.</title>
<authorList>
<person name="Kehrer-Sawatzki H."/>
<person name="Moschgath E."/>
<person name="Maier C."/>
<person name="Legius E."/>
<person name="Elgar G."/>
<person name="Krone W."/>
</authorList>
<dbReference type="PubMed" id="10863097"/>
<dbReference type="DOI" id="10.1016/S0378-1119(00)00188-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue evidence="8">Placenta</tissue>
</source>
</reference>
<reference key="2" evidence="23">
<citation type="submission" date="1999-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human LAK1 cDNA.</title>
<authorList>
<person name="Wang C."/>
<person name="Lo H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Amygdala</tissue>
</source>
</reference>
<reference key="4" evidence="23">
<citation type="submission" date="2005-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="131" last="139">
<title>The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling.</title>
<authorList>
<person name="Ishitani T."/>
<person name="Kishida S."/>
<person name="Hyodo-Miura J."/>
<person name="Ueno N."/>
<person name="Yasuda J."/>
<person name="Waterman M."/>
<person name="Shibuya H."/>
<person name="Moon R.T."/>
<person name="Ninomiya-Tsuji J."/>
<person name="Matsumoto K."/>
</authorList>
<dbReference type="PubMed" id="12482967"/>
<dbReference type="DOI" id="10.1128/MCB.23.1.131-139.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genes Dev." volume="18" first="381" last="386">
<title>Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction.</title>
<authorList>
<person name="Ohkawara B."/>
<person name="Shirakabe K."/>
<person name="Hyodo-Miura J."/>
<person name="Matsuo R."/>
<person name="Ueno N."/>
<person name="Matsumoto K."/>
<person name="Shibuya H."/>
</authorList>
<dbReference type="PubMed" id="15004007"/>
<dbReference type="DOI" id="10.1101/gad.1166904"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="8" evidence="22">
<citation type="journal article" date="2004" name="Genes Dev." volume="18" first="816" last="829">
<title>Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.</title>
<authorList>
<person name="Kanei-Ishii C."/>
<person name="Ninomiya-Tsuji J."/>
<person name="Tanikawa J."/>
<person name="Nomura T."/>
<person name="Ishitani T."/>
<person name="Kishida S."/>
<person name="Kokura K."/>
<person name="Kurahashi T."/>
<person name="Ichikawa-Iwata E."/>
<person name="Kim Y."/>
<person name="Matsumoto K."/>
<person name="Ishii S."/>
</authorList>
<dbReference type="PubMed" id="15082531"/>
<dbReference type="DOI" id="10.1101/gad.1170604"/>
</citation>
<scope>INTERACTION WITH MYB AND HIPK2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="17232" last="17240">
<title>Wnt activates the Tak1/Nemo-like kinase pathway.</title>
<authorList>
<person name="Smit L."/>
<person name="Baas A."/>
<person name="Kuipers J."/>
<person name="Korswagen H."/>
<person name="van de Wetering M."/>
<person name="Clevers H."/>
</authorList>
<dbReference type="PubMed" id="14960582"/>
<dbReference type="DOI" id="10.1074/jbc.M307801200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="4524" last="4529">
<title>STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylation.</title>
<authorList>
<person name="Kojima H."/>
<person name="Sasaki T."/>
<person name="Ishitani T."/>
<person name="Iemura S."/>
<person name="Zhao H."/>
<person name="Kaneko S."/>
<person name="Kunimoto H."/>
<person name="Natsume T."/>
<person name="Matsumoto K."/>
<person name="Nakajima K."/>
</authorList>
<dbReference type="PubMed" id="15764709"/>
<dbReference type="DOI" id="10.1073/pnas.0500679102"/>
</citation>
<scope>FUNCTION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH MAP3K7 AND STAT3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="20749" last="20760">
<title>NARF, an nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF).</title>
<authorList>
<person name="Yamada M."/>
<person name="Ohnishi J."/>
<person name="Ohkawara B."/>
<person name="Iemura S."/>
<person name="Satoh K."/>
<person name="Hyodo-Miura J."/>
<person name="Kawachi K."/>
<person name="Natsume T."/>
<person name="Shibuya H."/>
</authorList>
<dbReference type="PubMed" id="16714285"/>
<dbReference type="DOI" id="10.1074/jbc.M602089200"/>
</citation>
<scope>INTERACTION WITH RNF138 AND TCF7L2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Nat. Cell Biol." volume="9" first="1273" last="1285">
<title>A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation.</title>
<authorList>
<person name="Takada I."/>
<person name="Mihara M."/>
<person name="Suzawa M."/>
<person name="Ohtake F."/>
<person name="Kobayashi S."/>
<person name="Igarashi M."/>
<person name="Youn M.Y."/>
<person name="Takeyama K."/>
<person name="Nakamura T."/>
<person name="Mezaki Y."/>
<person name="Takezawa S."/>
<person name="Yogiashi Y."/>
<person name="Kitagawa H."/>
<person name="Yamada G."/>
<person name="Takada S."/>
<person name="Minami Y."/>
<person name="Shibuya H."/>
<person name="Matsumoto K."/>
<person name="Kato S."/>
</authorList>
<dbReference type="PubMed" id="17952062"/>
<dbReference type="DOI" id="10.1038/ncb1647"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH CHD7; PPARG AND SETDB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-167</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-298 AND SER-522</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-298</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="8122" last="8129">
<title>Regulation of FOXO1 by TAK1-Nemo-like kinase pathway.</title>
<authorList>
<person name="Kim S."/>
<person name="Kim Y."/>
<person name="Lee J."/>
<person name="Chung J."/>
</authorList>
<dbReference type="PubMed" id="20061393"/>
<dbReference type="DOI" id="10.1074/jbc.M110.101824"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FOXO1</scope>
<scope>MUTAGENESIS OF LYS-167</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="278" last="285">
<title>Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex.</title>
<authorList>
<person name="Ishitani T."/>
<person name="Hirao T."/>
<person name="Suzuki M."/>
<person name="Isoda M."/>
<person name="Ishitani S."/>
<person name="Harigaya K."/>
<person name="Kitagawa M."/>
<person name="Matsumoto K."/>
<person name="Itoh M."/>
</authorList>
<dbReference type="PubMed" id="20118921"/>
<dbReference type="DOI" id="10.1038/ncb2028"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NOTCH1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="Antioxid. Redox Signal." volume="14" first="563" last="578">
<title>Oxidative stress-dependent regulation of Forkhead box O4 activity by nemo-like kinase.</title>
<authorList>
<person name="Szypowska A.A."/>
<person name="de Ruiter H."/>
<person name="Meijer L.A.T."/>
<person name="Smits L.M.M."/>
<person name="Burgering B.M.T."/>
</authorList>
<dbReference type="PubMed" id="20874444"/>
<dbReference type="DOI" id="10.1089/ars.2010.3243"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FOXO1; FOXO3 AND FOXO4</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="19170" last="19177">
<title>Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4).</title>
<authorList>
<person name="Togi S."/>
<person name="Ikeda O."/>
<person name="Kamitani S."/>
<person name="Nakasuji M."/>
<person name="Sekine Y."/>
<person name="Muromoto R."/>
<person name="Nanbo A."/>
<person name="Oritani K."/>
<person name="Kawai T."/>
<person name="Akira S."/>
<person name="Matsuda T."/>
</authorList>
<dbReference type="PubMed" id="21454679"/>
<dbReference type="DOI" id="10.1074/jbc.M110.189829"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DAPK3 AND TCF7L2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-298</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="Mol. Cell. Biol." volume="35" first="778" last="788">
<title>Stabilization of ATF5 by TAK1-Nemo-like kinase critically regulates the interleukin-1beta-stimulated C/EBP signaling pathway.</title>
<authorList>
<person name="Zhang Z.Y."/>
<person name="Li S.Z."/>
<person name="Zhang H.H."/>
<person name="Wu Q.R."/>
<person name="Gong J."/>
<person name="Liang T."/>
<person name="Gao L."/>
<person name="Xing N.N."/>
<person name="Liu W.B."/>
<person name="Du R.L."/>
<person name="Zhang X.D."/>
</authorList>
<dbReference type="PubMed" id="25512613"/>
<dbReference type="DOI" id="10.1128/MCB.01228-14"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ATF5</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] THR-343</scope>
</reference>
<comment type="function">
<text evidence="5 9 10 11 13 16 17 18 19 20 21">Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1. Upon IL1B stimulus, cooperates with ATF5 to activate the transactivation activity of C/EBP subfamily members. Phosphorylates ATF5 but also stabilizes ATF5 protein levels in a kinase-independent manner (PubMed:25512613).</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="4">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="4 9 11">Activated by dimerization and subsequent intermolecular autophosphorylation on Thr-298 (By similarity). Activated by the non-canonical Wnt signaling pathway, in which WNT5A treatment leads to activation of MAP3K7/TAK1 and HIPK2, which subsequently phosphorylates and activates this protein. Other cytokines such as IL6 may also activate this regulatory circuit.</text>
</comment>
<comment type="subunit">
<text evidence="4 12 13 14 16 17 18 19 20 21">Homodimer. Homodimerization is required for intermolecular autophosphorylation, kinase activation and nuclear localization (By similarity). May interact with components of cullin-RING-based SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes (By similarity). Interacts with LEF1, MEF2A, MYBL1 and MYBL2 (By similarity). Interacts with the upstream activating kinases HIPK2 and MAP3K7/TAK1. Interaction with MAP3K7/TAK1 seems to be indirect, and may be mediated by other proteins such as STAT3, TAB1 and TAB2. Interacts with and phosphorylates a number of transcription factors including FOXO1, FOXO3, FOXO4, MYB, NOTCH1 and TCF7L2/TCF4. Interacts with DAPK3/ZIPK, and this interaction may disrupt interaction with transcription factors such as TCF7L2/TCF4. Forms a transcriptional repressor complex with CHD7, PPARG and SETDB1. Interacts with RNF138/NARF. Interacts with ATF5; the interaction stabilizes ATF5 at the protein level in a kinase-independent manner (PubMed:25512613).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-77293">
<id>O43293</id>
<label>DAPK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-747754">
<id>P28799</id>
<label>GRN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-10172511">
<id>Q9BYR5</id>
<label>KRTAP4-2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-10250562">
<id>Q6L8G9</id>
<label>KRTAP5-6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-3958099">
<id>P26371</id>
<label>KRTAP5-9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-358684">
<id>O43318</id>
<label>MAP3K7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-2798044">
<id>Q2TAL8</id>
<label>QRICH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-947779">
<id>Q96PM5</id>
<label>RCHY1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-347263">
<id>Q13485</id>
<label>SMAD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-749713">
<id>Q14186</id>
<label>TFDP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366978"/>
<interactant intactId="EBI-948582">
<id>Q9H4I2</id>
<label>ZHX3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Cytoplasm</location>
</subcellularLocation>
<text evidence="4">Predominantly nuclear. A smaller fraction is cytoplasmic (By similarity).</text>
</comment>
<comment type="domain">
<text>Contains a TQE activation loop motif in which autophosphorylation of the threonine residue (Thr-298) is sufficient for kinase activation. This mode of activation contrasts with that of classical MAP kinases, which contain a TXY activation loop motif in which phosphorylation of both the threonine and tyrosine residues is required for kinase activation.</text>
</comment>
<comment type="PTM">
<text>Phosphorylated on Thr-298. Intermolecular autophosphorylation on Thr-298 activates the enzyme.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.</text>
</comment>
<comment type="sequence caution" evidence="22">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAD56013" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="22">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAF04857" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="22">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="ABC40748" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="22">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG37718" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<dbReference type="EC" id="2.7.11.24"/>
<dbReference type="EMBL" id="AF197898">
<property type="protein sequence ID" value="AAF04857.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF180819">
<property type="protein sequence ID" value="AAD56013.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315315">
<property type="protein sequence ID" value="BAG37718.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ316259">
<property type="protein sequence ID" value="ABC40748.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC064663">
<property type="protein sequence ID" value="AAH64663.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11224.2"/>
<dbReference type="RefSeq" id="NP_057315.3">
<property type="nucleotide sequence ID" value="NM_016231.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.208759"/>
<dbReference type="ProteinModelPortal" id="Q9UBE8"/>
<dbReference type="SMR" id="Q9UBE8"/>
<dbReference type="BioGrid" id="119685">
<property type="interactions" value="58"/>
</dbReference>
<dbReference type="CORUM" id="Q9UBE8"/>
<dbReference type="IntAct" id="Q9UBE8">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="MINT" id="MINT-2873487"/>
<dbReference type="STRING" id="9606.ENSP00000384625"/>
<dbReference type="BindingDB" id="Q9UBE8"/>
<dbReference type="ChEMBL" id="CHEMBL5364"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2125"/>
<dbReference type="iPTMnet" id="Q9UBE8"/>
<dbReference type="PhosphoSitePlus" id="Q9UBE8"/>
<dbReference type="BioMuta" id="NLK"/>
<dbReference type="DMDM" id="262527551"/>
<dbReference type="PaxDb" id="Q9UBE8"/>
<dbReference type="PeptideAtlas" id="Q9UBE8"/>
<dbReference type="PRIDE" id="Q9UBE8"/>
<dbReference type="Ensembl" id="ENST00000407008">
<property type="protein sequence ID" value="ENSP00000384625"/>
<property type="gene ID" value="ENSG00000087095"/>
</dbReference>
<dbReference type="GeneID" id="51701"/>
<dbReference type="KEGG" id="hsa:51701"/>
<dbReference type="UCSC" id="uc010crj.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="51701"/>
<dbReference type="DisGeNET" id="51701"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000087095.12"/>
<dbReference type="GeneCards" id="NLK"/>
<dbReference type="HGNC" id="HGNC:29858">
<property type="gene designation" value="NLK"/>
</dbReference>
<dbReference type="HPA" id="HPA018192"/>
<dbReference type="HPA" id="HPA056511"/>
<dbReference type="MIM" id="609476">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UBE8"/>
<dbReference type="OpenTargets" id="ENSG00000087095"/>
<dbReference type="PharmGKB" id="PA134914500"/>
<dbReference type="eggNOG" id="KOG0664">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XRAQ">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140938"/>
<dbReference type="HOGENOM" id="HOG000233024"/>
<dbReference type="HOVERGEN" id="HBG014652"/>
<dbReference type="InParanoid" id="Q9UBE8"/>
<dbReference type="KO" id="K04468"/>
<dbReference type="OMA" id="KCCYTTS"/>
<dbReference type="OrthoDB" id="EOG091G05X6"/>
<dbReference type="PhylomeDB" id="Q9UBE8"/>
<dbReference type="TreeFam" id="TF315210"/>
<dbReference type="Reactome" id="R-HSA-4086398">
<property type="pathway name" value="Ca2+ pathway"/>
</dbReference>
<dbReference type="SignaLink" id="Q9UBE8"/>
<dbReference type="SIGNOR" id="Q9UBE8"/>
<dbReference type="ChiTaRS" id="NLK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="NLK"/>
<dbReference type="GenomeRNAi" id="51701"/>
<dbReference type="PRO" id="PR:Q9UBE8"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000087095"/>
<dbReference type="CleanEx" id="HS_NLK"/>
<dbReference type="ExpressionAtlas" id="Q9UBE8">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UBE8">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004707">
<property type="term" value="F:MAP kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042169">
<property type="term" value="F:SH2 domain binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030178">
<property type="term" value="P:negative regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042501">
<property type="term" value="P:serine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007223">
<property type="term" value="P:Wnt signaling pathway, calcium modulating pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003527">
<property type="entry name" value="MAP_kinase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01351">
<property type="entry name" value="MAPK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="chain" description="Serine/threonine-protein kinase NLK" id="PRO_0000186336">
<location>
<begin position="1"/>
<end position="527"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="6">
<location>
<begin position="138"/>
<end position="427"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="6">
<location>
<begin position="144"/>
<end position="152"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with TAB2" evidence="4">
<location>
<begin position="1"/>
<end position="304"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for interaction with DAPK3" evidence="20">
<location>
<begin position="1"/>
<end position="125"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for interaction with DAPK3" evidence="20">
<location>
<begin position="124"/>
<end position="416"/>
</location>
</feature>
<feature type="region of interest" description="Required for homodimerization and kinase activation and localization to the nucleus" evidence="4">
<location>
<begin position="428"/>
<end position="527"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with TAB2" evidence="4">
<location>
<begin position="434"/>
<end position="527"/>
</location>
</feature>
<feature type="short sequence motif" description="TQE">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="22"/>
<end position="25"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="27"/>
<end position="34"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="42"/>
<end position="48"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="71"/>
<end position="83"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="106"/>
<end position="111"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="115"/>
<end position="119"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="6 7">
<location>
<position position="264"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="22">
<location>
<position position="167"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="1 2 3">
<location>
<position position="298"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="522"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11871287." id="VAR_019549">
<original>V</original>
<variation>A</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In a glioblastoma multiforme sample; somatic mutation." id="VAR_042273" evidence="15">
<original>A</original>
<variation>T</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates kinase activity." evidence="16 17">
<original>K</original>
<variation>N</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH64663." ref="5" evidence="22">
<original>A</original>
<variation>T</variation>
<location>
<position position="25"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O54949"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10863097"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12482967"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14960582"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15004007"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15082531"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15764709"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16714285"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17952062"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20061393"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20118921"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20874444"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454679"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25512613"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<evidence key="23" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAD56013.1"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAF04857.1"/>
</source>
</evidence>
<sequence length="527" mass="58283" checksum="CE6AEBA7D8133989" modified="2009-11-03" version="2">
MSLCGARANAKMMAAYNGGTSAAAAGHHHHHHHHLPHLPPPHLHHHHHPQHHLHPGSAAA
VHPVQQHTSSAAAAAAAAAAAAAMLNPGQQQPYFPSPAPGQAPGPAAAAPAQVQAAAAAT
VKAHHHQHSHHPQQQLDIEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK
RVFRELKMLCFFKHDNVLSALDILQPPHIDYFEEIYVVTELMQSDLHKIIVSPQPLSSDH
VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEELDESRHMTQE
VVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP
SLEAMRTACEGAKAHILRGPHKQPSLPVLYTLSSQATHEAVHLLCRMLVFDPSKRISAKD
ALAHPYLDEGRLRYHTCMCKCCFSTSTGRVYTSDFEPVTNPKFDDTFEKNLSSVRQVKEI
IHQFILEQQKGNRVPLCINPQSAAFKSFISSTVAQPSEMPPSPLVWE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>